Universität Zürich opposition analysis

COMPANY ANALYSIS

Latest patents of Universität Zürich opposed by its competitors

Patent:
Grant Date:
Jun 2, 2021
Title:
Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy
Oppositions:
5
Patent:
Grant Date:
Nov 4, 2020
Title:
Perfusion Loop Assembly For An Ex-Vivo Liver Perfusion And A Liver Chamber Assembly
Oppositions:
1
Patent:
Grant Date:
Aug 21, 2019
Title:
Means And Methods For Identifying A Patient Having A Braf-Positive Cancer As A Non-Responder To A Braf Inhibitor And As A Responder To An Mapk/Erk Inhibitor
Oppositions:
1
Patent:
Grant Date:
May 10, 2017
Title:
Integrin Alpha(V)Beta(6) For Diagnosis/Prognosis Of Colorectal Carcinoma
Oppositions:
1

Want to track Universität Zürich?

Feel free to send us a message here and we will get back to you